Your browser doesn't support javascript.
loading
Inhibitors of phosphoinositide 3-kinase (PI3K) and phosphoinositide 3-kinase-related protein kinase family (PIKK).
Huang, Xueqin; You, Li; Nepovimova, Eugenie; Psotka, Miroslav; Malinak, David; Valko, Marian; Sivak, Ladislav; Korabecny, Jan; Heger, Zbynek; Adam, Vojtech; Wu, Qinghua; Kuca, Kamil.
Afiliação
  • Huang X; College of Life Science, Yangtze University, Jingzhou, China.
  • You L; College of Physical Education and Health, Chongqing College of International Business and Economics, Chongqing, China.
  • Nepovimova E; Department of Chemistry, Faculty of Science, University of Hradec Kralove, Czech Republic.
  • Psotka M; Department of Chemistry, Faculty of Science, University of Hradec Kralove, Czech Republic.
  • Malinak D; Biomedical Research Center, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.
  • Valko M; Department of Chemistry, Faculty of Science, University of Hradec Kralove, Czech Republic.
  • Sivak L; Biomedical Research Center, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.
  • Korabecny J; Faculty of Chemical and Food Technology, Slovak University of Technology in Bratislava, Bratislava, Slovakia.
  • Heger Z; Department of Chemistry and Biochemistry, Mendel University in Brno, Brno, Czech Republic.
  • Adam V; Biomedical Research Center, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.
  • Wu Q; Department of Chemistry and Biochemistry, Mendel University in Brno, Brno, Czech Republic.
  • Kuca K; Department of Chemistry and Biochemistry, Mendel University in Brno, Brno, Czech Republic.
J Enzyme Inhib Med Chem ; 38(1): 2237209, 2023 Dec.
Article em En | MEDLINE | ID: mdl-37489050

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fosfatidilinositol 3-Quinase / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fosfatidilinositol 3-Quinase / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article